Osama Sanad (MD) Prof. of Cardiology Benha University 2016

Similar documents
None. Disclosure: Relationships with Industry Conflicts of Interests. Learning Objectives: Participants will be able to:

JNC Evidence-Based Guidelines for the Management of High Blood Pressure in Adults

Update on Current Trends in Hypertension Management

Hypertension Guidelines: Lessons for Primary Care. Paul A James MD Professor and Chair Department of Family Medicine University of Washington

DISCLOSURE PHARMACIST OBJECTIVES 9/30/2014 JNC 8: A REVIEW OF THE LONG-AWAITED/MUCH-ANTICIPATED HYPERTENSION GUIDELINES. I have nothing to disclose.

Hypertension Guidelines 2017

Int. J. Pharm. Sci. Rev. Res., 36(1), January February 2016; Article No. 06, Pages: JNC 8 versus JNC 7 Understanding the Evidences

HYPERTENSION GUIDELINES WHERE ARE WE IN 2014

JNC 8 -Controversies. Sagren Naidoo Nephrologist CMJAH

ΑΡΥΙΚΗ ΠΡΟΔΓΓΙΗ ΤΠΔΡΣΑΙΚΟΤ ΑΘΔΝΟΤ. Μ.Β.Παπαβαζιλείοσ Καρδιολόγος FESC - Γιεσθύνηρια ιζμανόγλειον ΓΝΑ Clinical Hypertension Specialist ESH

Controlling Hypertension in Primary Care: Hitting a moving target?

Hypertension and the SPRINT Trial: Is Lower Better

4/4/17 HYPERTENSION TARGETS: WHAT DO WE DO NOW? SET THE STAGE BP IN CLINICAL TRIALS?

Todd S. Perlstein, MD FIFTH ANNUAL SYMPOSIUM

Managing HTN in the Elderly: How Low to Go

Which antihypertensives are more effective in reducing diastolic hypertension versus systolic hypertension? May 24, 2017

Director of the Israeli Institute for Quality in Medicine Israeli Medical Association July 1st, 2016

Preventing heart disease by controlling hypertension: Impact of hypertensive subtype, stage, age, and sex

2017 High Blood Pressure Clinical Practice Guideline

Management of Hypertension in special groups. DR-Mohammed Salah Assistant Lecturer of Cardiology Mansoura University

HYPERTENSION: ARE WE GOING TOO LOW?

Long-Term Care Updates

HYPERTENSION: UPDATE 2018

New Hypertension Guidelines: Why the change? Neil Brummond, M.D. Avera Medical Group Internal Medicine Sioux Falls, SD

An Epidemiological Overview

Chapman University Digital Commons. Chapman University. Michael S. Kelly Chapman University,

Objectives. JNC 7 Is Nice But What s Up With JNC 8? Why Do We Care? Hypertension Background: Prevalence

Clinical Updates in the Treatment of Hypertension JNC 7 vs. JNC 8. Lauren Thomas, PharmD PGY1 Pharmacy Practice Resident South Pointe Hospital

NIH Public Access Author Manuscript JAMA Intern Med. Author manuscript; available in PMC 2015 August 01.

An Epidemiological Overview

Hypertension Update 2009

T. Suithichaiyakul Cardiomed Chula

Cardiovascular disease (CVD), including stroke, is the

Objectives. Describe results and implications of recent landmark hypertension trials

Best Practices in Cardiac Care: Getting with the Guidelines

Data Fact Sheet. Congestive Heart Failure in the United States: A New Epidemic

Understanding the importance of blood pressure control An overview of new guidelines: How do they impact daily current management?

Hypertension. Risk of cardiovascular disease beginning at 115/75 mmhg doubles with every 20/10mm Hg increase. (Grade B)

Status Report on the NHLBI-Sponsored CVD Prevention Guidelines

Hypertension Update 2016 AREEF ISHANI, MD MS CHIEF OF MEDICINE MINNEAPOLIS VA MEDICAL CENTER PROFESSOR OF MEDICINE UNIVERSITY OF MINNESOTA

Hypertension and obesity. Dr Wilson Sugut Moi teaching and referral hospital

Hypertension JNC 8 (2014)

Combination Therapy for Hypertension

Hypertension Update Background

Study of Serum Uric Acid Level in Hypertension

Recent Hypertension Guidelines

TIP. Documentation and coding guide. Disease definitions* Prevalence and statistics associated with HTN**

Hypertension Update. Aaron J. Friedberg, MD

2003 World Health Organization (WHO) / International Society of Hypertension (ISH) Statement on Management of Hypertension.

CONTRIBUTING FACTORS FOR STROKE:

New Recommendations for the Treatment of Hypertension: From Population Salt Reduction to Personalized Treatment Targets

Hypertension Guidelines: Are We Pressured to Change? Oregon Cardiovascular Symposium Portland, Oregon June 6, Financial Disclosures

HYPERTENSION AND HEART FAILURE

2/11/2019 CLINICAL IMPLEMENTATION OF THE UPDATED BP GUIDELINES DUALITY OF INTEREST

Blood Pressure LIMBO How Low To Go?

Hypertension Guidelines JNC Recommendations. Robert E. Bulow DO FACOI, FACC

Jared Moore, MD, FACP

HYPERTENSION MANAGEMENT IN ELDERLY POPULATIONS

Disclosure. Instead of JNC 8. Proposed Reasons for Delays. Outline 6/10/2013. Member of JNC 8 panel No other disclosures. Daniel T.

Using the New Hypertension Guidelines

DEPARTMENT OF GENERAL MEDICINE WELCOMES

Prevention of Heart Failure: What s New with Hypertension

Egyptian Hypertension Guidelines

Hypertension Management Controversies in the Elderly Patient

2. Measurement Specifications 3. Patient Messaging 4. Provider Messaging Other Recent Guidelines

Diversity and HTN: Approaches to optimal BP control in AfricanAmericans

Renal Denervation. by Walead Latif, DO, MBA, CPE Assistant Clinical Professor Rutgers Medical School

SBP in range of 120 to 140 :no progression or regression of CAD. Sipahi et al., 2006

Clinical Recommendations: Patients with Periodontitis

2009 Shattuck Lecture

Metoprolol Succinate SelokenZOC

Patient is healthy with no chronic disease or significant risk factors [16%].

Epidemiologic Measure of Association

C h a p t e r 1 7 JNC 7 Guidelines and Indian Scenario

The Latest Generation of Clinical

Layered Approaches to Studying Drug Responses

New Clinical Trends in Geriatric Medicine. April 8, 2016 Amanda Lathia, MD, MPhil Staff, Center for Geriatric Medicine

Pre-ALLHAT Drug Use. Diuretics. ß-Blockers. ACE Inhibitors. CCBs. Year. % of Treated Patients on Medication. CCBs. Beta Blockers.

Evolving Concepts on Hypertension: Implications of Three Guidelines (JNC 8 Panel, ESH/ESC, NICE/BSH)

Management of Hypertension: JNC 8 and Beyond

ALLHAT. Major Outcomes in High Risk Hypertensive Patients Randomized to Angiotensin-Converting Enzyme Inhibitor or Calcium Channel Blocker vs Diuretic

VA/DoD Clinical Practice Guideline for the Diagnosis and Management of Hypertension - Pocket Guide Update 2004 Revision July 2005

Hypertension Management Focus on new RAAS blocker. Disclosure

Hypertension Update Clinical Controversies Regarding Age and Race

New Hypertension Guideline Recommendations for Adults July 7, :45-9:30am

ARIC Manuscript Proposal # PC Reviewed: 2/10/09 Status: A Priority: 2 SC Reviewed: Status: Priority:

JNC-8. (Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure- 8) An Update on Hypertension Guidelines

What s In the New Hypertension Guidelines?

The Hypertension Clinic is a part of the Internal Medicine

Management of High Blood Pressure in Adults

Renal Disease through the Ages: From Childbearing years to Old Age. Dr Elizabeth Jarvis, Renal Physician, General Physician, Obstetric Physician.

Prevalence of Comorbidities and Their Influence on Blood Pressure Goal Attainment in Geriatric Patients

MODERN MANAGEMENT OF HYPERTENSION Where Do We Draw the Line? Disclosure. No relevant financial relationships. Blood Pressure and Risk

10/21/2014. Disclosures. Introduction. Reasons for the Decline in Stroke Mortality: Implications for Hypertension and Risk Factor Management

2/10/2014. Hypertension: Highlights of Hypertension Guidelines: Making the Most of Limited Evidence. Issues with contemporary guidelines

MANAGEMENT OF HYPERTENSION: TREATMENT THRESHOLDS AND MEDICATION SELECTION

Reframe the Paradigm of Hypertension treatment Focus on Diabetes

Hypertension targets: sorting out the confusion. Brian Rayner, Division of Nephrology and Hypertension, University of Cape Town

Slide notes: References:

Transcription:

Osama Sanad (MD) Prof. of Cardiology Benha University 2016

Back in time. 1912

Back in time. 1912 No body knows that hypertension is a lethal disease

Hypertension in 1940s Among anti-hypertensives mentioned were thiocyanates, barbiturates, Bithmus and bromides!! Franklin Roosevelt represents an open textbook for the natural history of untreated HTN In 1937, BP 160/100 with no symptoms and no treatment. In 1941, BP 180/110 with heart failure symptoms treated with digitalis! In 1945, he died of cerebral hage. with BP 300/190!!

A Historical Prospective 1946 Textbook - Diseases of the Heart, Friedberg People with mild benign hypertension with levels up to 210/110 need not be treated There is a psychopathologic personality associated with hypertension

Hypertension in 1950s Dr. Harrison stated in PRINCIPLES OF INTERNAL MEDICINE that hypertension should be treated ONLY when coronary symptoms occur. Hydralazine was first discovered but its use was limited due to side effects. In 1957, Thiazide diuretics were discovered and used as effective drugs to lower BP safely. In late 1950s, Page et al. provided the 1 st mosaic theory for HTN pathogenesis as a multifactorial disease involving kidney, liver and endocrine-nervous system.

if we still guided by the old information we might still treat our HTN patients to 200/100mmHg as a target

Plethora of HTN guidelines

US Hypertension Guideline Mania

The Joint National Committee (JNC ) 1 2 3 4 5 6 7 8 1977 1980 1984 1988 1993 1997 2003 2014????????

Hypertension in 1960s to 1990s During 1960s, debate continued as whether to treat HTN or not!! In late 1960s, Framingham Heart Study was reported a strong correlation between HTN and heart attacks, congestive heart failure and strokes. After that, discovery of ß-blockers changed the paradigm.

JNC 1 recommendations (1977) 1.BP of 160/95 should not be treated and should be re-checked one month later in all. 2.Persons younger than 50 years with BP 140/90 & < 160/95 should be re-checked in 2-3 months. 3.Persons older than 50 years with the above range should be re-assessed in 6-9 months. 4.DO NOT treat HTN as long as diastolic BP is 105 mmhg!! 5.The emphasis of JNC-I was only on diastolic BP.

Through JNC -2 & 3 (1980-1984) BP target goals were arbitrary and classification Systems were vague

JNC-4 first introduced a classification system (1988) JNC 5 changed the classification system a little bit (1993)

1997

Hypertension JNC DBP Classifications from 1977 : 2003 130 125 Stage 4 DBP (mm Hg) 120 115 110 105 Hypertensive Severe Severe Severe Moderate Moderate Moderate Stage 3 Stage 3 Stage 2 Stage 2 Stage 2 100 95 Consider therapy Mild Mild Mild Stage 1 Stage 1 Stage 1 90 85 80 Normal Normal Normal Normal Optimal Optimal Highnormal Highnormal Highnormal Highnormal Prehypertension Normal JNC I JNC II JNC III JNC IV JNC V JNC VI JNC 7 JNC I. JAMA. 1977;237:255-261. JNC II. Arch Intern Med. 1980;140:1280-1285. JNC III. Arch Intern Med. 1984;144:1045-1057. JNC IV. Arch Intern Med. 1988;148:1023-1038. JNC V. Arch Intern Med. 1993;153:154-183. JNC VI. Arch Intern Med. 1997;157:2413-2446. Chobanian AV et al. JAMA. 2003;289:2560-2572.

Hypertension JNC SBP Classifications: from 1977 : 2003 220 Stage 4 210 SBP (mm Hg) 200 190 180 170 160 150 140 130 120 110 No recommendations for SBP in JNC I or JNC II ISH ISH Normal Stage 2 Stage 1 Borderline Stage 3 Stage 3 Stage 2 Stage 2 Stage 1 Stage 1 Highnormal Highnormal Normal Normal Optimal Optimal Borderline Prehypertension Normal JNC I JNC II JNC III JNC IV JNC V JNC VI JNC 7 JNC I. JAMA. 1977;237:255-261. JNC II. Arch Intern Med. 1980;140:1280-1285. JNC III. Arch Intern Med. 1984;144:1045-1057. JNC IV. Arch Intern Med. 1988;148:1023-1038. JNC V. Arch Intern Med. 1993;153:154-183. JNC VI. Arch Intern Med. 1997;157:2413-2446. Chobanian AV et al. JAMA. 2003;289:2560-2572.

2003 2014

More simplified classification system

What's Changed : JNC 7 vs JNC 8 JNC 7 recommended a treatment threshold of 140/90 mm Hg regardless of age, whereas JNC 8 raises the systolic threshold at age 60. In addition, JNC 7 recommended a lower treatment threshold (130/80 mm Hg) for patients with diabetes or chronic kidney disease, but JNC 8 does not. Controversy surrounds long-awaited JNC 8 guideline

The controversial JNC 8 relaxed BP goals from 140/90 to 150/90

Is JNC 8 s hypertension treatment threshold too high?

JNC 8 Headlines The JNC 8 Hypertension Guidelines: An In-Depth Guide Despite Controversy, JNC 8 Guideline Provides Muchneeded Standards for Hypertension Management Hypertension Guidelines: Clear as Mud Blood pressure targets: are clinical guidelines wrong? A call to retract the JNC-8 hypertension guidelines

AHA: JNC 8 Putting Older Adults at Risk? Analysis warns of potential harm from BP guideline change. New Analysis Questions Higher JNC 8's SBP Target for Patients Over 60

Proportion of US Adults Potentially Affected by the 2014 Hypertension Guideline JAMA. 2014;311(14):1424-1429. If the JNC 8 recommendations are used:- 6 million adults in the US aged 60 years and older would be ineligible for treatment with antihypertensive drugs. Treatment intensity would be decreased for an additional 13.5 million older persons. Increase IN incidences of coronary events, stroke, heart failure, cardiovascular mortality, and other adverse events associated with inadequate control of hypertension.

Impact of the 2014 Expert Panel Recommendations for Management of High Blood Pressure on Contemporary Cardiovascular Practice : Insights From the NCDR PINNACLE Registry J Am Coll Cardiol. 2014 Dec 2;64(21):2196-203 Of 1,185,253 patients in the study cohort:- 706,859 (59.6%) achieved the 2003 JNC-7 goals. 880,378 (74.3%) achieved the 2014 LNC-8 goals. Nearly 1 in 7 who did not meet JNC-7 recommendations would now meet the 2014 treatment goals. NCDR, National Cardiovascular Data Registry; PINNACLE, Practice Innovation and Clinical Excellence

A guidelinechanging trial?? New Hypertension Recommendations Anticipated in 2016

Conclusion The aim of science is:- Not to open a door to endless Wisdom But to put a limit to endless error

The new recommendations are expected to be In the next years